Based on available evidence from various transgenic mouse models (reviewed in [77]), the PPAR family of nuclear receptors, as well as histone deacetylases, are key regulators of genes for lipid oxidation in enterocytes, and their genetic manipulation has led to reduced weight gain, hepatic steatosis and serum TAG levels, and improved glucose tolerance. This evidence concerns the gene PPARA and fatty liver disease.